XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
SHAREHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2023
Jul. 31, 2022
Apr. 30, 2022
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Apr. 04, 2022
Apr. 30, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Options to acquire shares     144,191            
Weighted exercise price     $ 10.71              
Warrants to purchase shares     4,424              
Exercise price     $ 7.32              
Expiration date     Apr. 22, 2031              
Cash consideration   $ 10,000,000.0                
Number of shares   486,145                
Number of shares issued, value         $ 1,033,761          
Stock granted and issued             108,136      
Restricted stock award, gross             $ 4,293,988      
Share-based compensation       $ 1,127,332   $ 703,400 1,724,637 $ 1,288,335    
Unrecognized share-based compensation expense       $ 4,844,361     $ 4,844,361      
Unrecognized share-based compensation expense period for recognition             1 year 2 months 12 days      
Purchase Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares   94,798                
Payments to acquire assets   $ 7,600,000                
Cash   $ 1,600,000                
Issuance of common stock for purchase of assets   291,686                
Net proceeds   $ 1,950,000                
Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares         26,143          
Warrants to purchase shares     12,301              
Exercise price     $ 12.05              
Expiration date     Aug. 10, 2030              
Number of shares issued, value         $ 26          
Common Stock [Member] | Sales Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares             26,143      
Number of shares issued, value             $ 1,066,000      
Net proceeds             $ 1,034,000      
Precision Healing [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Payment in cash     $ 600,000              
Share price     $ 27.13             $ 27.13
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Percentage of commissions payable to sales agent 3.00%                  
Cantor Fitzgerald and Co [Member] | Sales Agreement [Member] | Maximum [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Sale of stock, consideration received on transaction $ 75,000,000                  
Accredited Investors [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Accredited investors shares     165,738              
Nonaccredited Investors [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share price                 $ 30.75  
Precision Healing Inc [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Cash consideration     $ 125,966              
Payment of contingent consideration     $ 10,000,000.0              
Restated 2014 Omnibus Long Term Incentive Plan [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Number of shares available for issuance       1,412,196     1,412,196      
Restated 2014 Omnibus Long Term Incentive Plan [Member] | Directors Officers Employees [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock in equity offering, shares             587,804